Edition:
United Kingdom

People: Alexion Pharmaceuticals Inc (ALXN.OQ)

ALXN.OQ on NASDAQ Stock Exchange Global Select Market

107.98USD
3:42pm BST
Change (% chg)

$-0.56 (-0.52%)
Prev Close
$108.54
Open
$108.86
Day's High
$108.99
Day's Low
$107.90
Volume
97,993
Avg. Vol
710,078
52-wk High
$141.81
52-wk Low
$92.57

Nader, Francois 

Dr. Francois E. Nader, M.D. is Independent Director of the Company .He served as President, Chief Executive Officer, and Executive Director of NPS Pharma, a global biotechnology company that was focused on delivering innovative therapies to patients with rare diseases, from 2008 to 2015. Prior to NPS, Dr. Nader was a venture partner at Care Capital, a venture capital firm. He previously served on the North America Leadership Team of Aventis Pharma and its predecessor companies, holding a number of executive positions in integrated healthcare markets and medical and regulatory affairs. He also led global commercial operations at the Pasteur Vaccines division of Rhone-Poulenc. Dr. Nader earned his French Doctorate in Medicine from St. Joseph University in Lebanon and a physician executive MBA from the University of Tennessee.

Basic Compensation

Total Annual Compensation, USD 95,000
Restricted Stock Award, USD 253,858
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 348,858

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

David Brennan

448,858

Ludwig Hantson

16,490,200

Paul Clancy

5,486,510

Indrani Franchini

--

Ellen Chiniara

--

Anne-Marie Law

5,296,490
As Of  31 Dec 2018